Table 3. Posterior marginal log odds ratios for parameters.
| Arc | Log odds | |||
|---|---|---|---|---|
| Child | Parent | Median | Credibility interval | |
| 50% | 2.50% | 97.50% | ||
| aph(3’)-IIIa | ant(6)-Ia | 17.31 | 6.43 | 43.35 |
| aph(3’)-IIIa | erm(B) | 15.00 | 4.39 | 40.95 |
| erm(B) | tet(O) | −2.90 | −6.23 | −0.98 |
| erm(B) | tet(L) | 2.30 | 1.34 | 3.38 |
| tet(M) | tet(O) | −3.21 | −6.56 | −1.29 |
| tet(M) | tet(L) | 2.17 | 1.27 | 3.15 |
| tet(L) | ant(6)-Ia | 2.18 | 1.08 | 3.52 |
| Dihydrostreptomycin (Low) a | ant(6)-Ia | −2.58 | −5.90 | −0.78 |
| Dihydrostreptomycin (High) b | ant(6)-Ia | 7.53 | 4.82 | 12.13 |
| Dihydrostreptomycin (High) b | tet(M) | 3.33 | 1.36 | 6.63 |
| Erythromycin | erm(B) | 24.88 | 5.45 | 70.54 |
| Oxytetracycline (Low) c | tet(M) | 3.27 | 1.73 | 5.12 |
| Oxytetracycline (Low) c | tet(O) | 6.03 | 3.81 | 8.78 |
| Oxytetracycline (Low) c | tet(L) | −3.93 | −6.28 | −2.16 |
| Oxytetracycline (High) d | tet(O) | −4.25 | −6.66 | −2.37 |
| Oxytetracycline (High) d | tet(L) | 7.10 | 4.97 | 10.51 |
Posterior estimates for remaining arcs obtained from the final ABN model after bootstrapping. The median and 95% credibility intervals for each parameter estimate are shown.
aMIC for dihydrostreptomycin: ≥128 μg/mL and ≤512 μg/mL.
bMIC for dihydrostreptomycin: >512 μg/mL.
cMIC for oxytetracycline: ≥16 μg/mL and ≤64 μg/mL.
dMIC for oxytetracycline: >64 μg/mL.